Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.

Syrimi, Eleni; Gunasekera, Sanjeeva; Norton, Alice; Velangi, Mark; Motwani, Jayashree; Hiwarkar, Prashant

Syrimi, Eleni; Gunasekera, Sanjeeva; Norton, Alice; Velangi, Mark; Motwani, Jayashree; Hiwarkar, Prashant.

Afiliação

Syrimi E; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.
Gunasekera S; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.
Norton A; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.
Velangi M; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.
Motwani J; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.
Hiwarkar P; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK.

Br J Haematol ; 181(5): 696-698, 2018 06.

Article em En | MEDLINE | ID: mdl-28480955

Assuntos

Neoplasias/terapia; Síndrome de Lise Tumoral/prevenção & controle; Urato Oxidase/administração & dosagem; Adolescente; Criança; Pré-Escolar; Feminino; Humanos; Lactente; Masculino; Neoplasias/sangue; Estudos Retrospectivos; Síndrome de Lise Tumoral/sangue

Palavras-chave

hyperuricaemia; single dose rasburicase; tumour lysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urato Oxidase / Síndrome de Lise Tumoral / Neoplasias Tipo de estudo: Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google